SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised by the drugs' clinical trials, a new study says. People taking such GLP ...

Zepbound is a weekly injectable prescription weight loss medication with the active ingredient tirzepatide. It’s a GLP-1 agonist drug that slows stomach emptying, meaning you feel fuller for ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main ... obstructive sleep apnoea, or cardiovascular disease, but without diabetes.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... obstructive sleep apnoea, or cardiovascular disease, but who did not have diabetes.

Health News // 1 day ago Study: Real-world results of GLP-1 drugs don't match trials Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as ...

Communities across Asia's Himalayan Hindu Kush region face heightened disaster risks this monsoon season with temperatures ...

Consumer prices were only slightly affected by President Donald Trump’s tariffs in May, according to new numbers from the U.S. Bureau of Labor Statistics.